BCAR1
2 papers study it1 finding
- 1 lab in 1 country
- Funder: Wilhelm Sander-Stiftung
- Humans1
- Cells1
Interventions
1Dasatinib + dexamethasone
downin human cells1
1 study
Dasatinib + dexamethasone
downin human cells1
Dasatinib + dexamethasone decreases BCAR1 in human cells.
“Dasatinib and Dexamethasone combination treatment showed strong synergistic effects on Src and p130Cas phosphorylation and led to reduced p130Cas expression.”
Cellscombination treatment in TSCC lines
Cell communication and signaling : CCS
Latest
Cell Communication and Signaling
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity
Experiments in human cellsGlucocorticoids
Communications Biology
Genome-wide association study reveals BET1L associated with survival time in the 137,693 Japanese individuals
Genetic association study of 137,693 peoplePopulations